CD4 and neoplasm: PD-L1 is a key player in tumor immune suppression, and studies have shown that PD-L1 signaling including PD-1/PD-L1 and CD80/PD-L1 is crucial for T cell migration, modulating transendothelial movements of Tregs and CD4 effector T cells [45].